MetaTOC stay on top of your field, easily

Impact of anti-peptic ulcer disease (PUD) medications on hyperlipidemia risk in patients with PUD: a population-based retrospective cohort study

, , , , , , , ,

Therapeutic Advances in Endocrinology and Metabolism

Published online on

Abstract

Therapeutic Advances in Endocrinology and Metabolism, Volume 17, January-December 2026.
Background:The causes of cardiovascular disease are complex, with hyperlipidemia being a major factor in its development. The connection between peptic ulcer disease (PUD) and hyperlipidemia is unclear, and there have been no thorough studies on the ...